Jane Wasman
2011
In 2011, Jane Wasman earned a total compensation of $1.6M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,457 |
|---|---|
| Option Awards | $687,941 |
| Salary | $388,100 |
| Stock Awards | $413,625 |
| Other | $7,350 |
| Total | $1,645,473 |
Wasman received $687.9K in option awards, accounting for 42% of the total pay in 2011.
Wasman also received $148.5K in non-equity incentive plan, $388.1K in salary, $413.6K in stock awards and $7.4K in other compensation.
Rankings
In 2011, Jane Wasman's compensation ranked 3,910th out of 10,747 executives tracked by ExecPay. In other words, Wasman earned more than 63.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,910 out of 10,747 | 64th |
Division Manufacturing | 1,372 out of 3,960 | 65th |
Major group Chemicals And Allied Products | 276 out of 1,033 | 73rd |
Industry group Drugs | 159 out of 781 | 80th |
Industry Biological Products, Except Diagnostic Substances | 21 out of 157 | 87th |
Source: SEC filing on April 25, 2014.
Wasman's colleagues
We found five more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2011.
2011
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2011
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2011
Thomas Wessel
Acorda Therapeutics
Chief Medical Officer
2011
David Lawrence
Acorda Therapeutics
Chief Financial Officer
2011
Lauren Sabella
Acorda Therapeutics